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FOXP2 was the first gene shown to cause a Mendelian form of speech and language
disorder. Although developmentally expressed in many organs, loss of a single copy of
FOXP2 leads to a phenotype that is largely restricted to orofacial impairment during
articulation and linguistic processing deficits. Why perturbed FOXP2 function affects
specific aspects of the developing brain remains elusive. We investigated the role
of FOXP2 in neuronal differentiation and found that FOXP2 drives molecular changes
consistent with neuronal differentiation in a human model system. We identified a
network of FOXP2 regulated genes related to retinoic acid signaling and neuronal
differentiation. FOXP2 also produced phenotypic changes associated with neuronal
differentiation including increased neurite outgrowth and reduced migration. Crucially, cells
expressing FOXP2 displayed increased sensitivity to retinoic acid exposure. This suggests
a mechanism by which FOXP2 may be able to increase the cellular differentiation response
to environmental retinoic acid cues for specific subsets of neurons in the brain. These
data demonstrate that FOXP2 promotes neuronal differentiation by interacting with the
retinoic acid signaling pathway and regulates key processes required for normal circuit
formation such as neuronal migration and neurite outgrowth. In this way, FOXP2, which is
found only in specific subpopulations of neurons in the brain, may drive precise neuronal
differentiation patterns and/or control localization and connectivity of these FOXP2 positive
cells.
Keywords: language, neurite outgrowth, forkhead transcription factors, FOXP2, retinoic acid, neuron
differentiation, SH-SY5Y cells, neuronal migration
INTRODUCTION
Mutations in the FOXP2 gene are known to cause rare forms
of speech and language disorder, the first report of which was
the KE family in 2001 (Lai et al., 2001). Additional FOXP2 gene
disruptions have since been identified in a number of unre-
lated individuals or families with similar phenotypes (Macdermot
et al., 2005; Shriberg et al., 2006; Palka et al., 2011; Rice et al., 2012;
Žilina et al., 2012). Affected individuals all carry heterozygous
mutations in FOXP2, meaning that they still have one functional
copy of the gene. A complete loss of FOXP2 is thought to be lethal
for humans, as it is in mouse models, likely due to developmental
defects in multiple organs (Lu et al., 2002; Shu et al., 2007; Rousso
et al., 2012). Although developmentally expressed in many tissues
including the brain, lung, and heart, reduced levels of functional
FOXP2 results in a phenotype that is largely restricted to orofacial
impairment during articulation and linguistic processing deficits
in patients (Vargha-Khadem et al., 1995; Alcock et al., 2000;
Watkins et al., 2002a). This highly specific phenotype suggests
that particular aspects of the nervous system have a lower toler-
ance for FOXP2 reduction than other tissues, such as the heart or
lung. The effect of FOXP2 mutation on brain structure and func-
tion has been studied in members of the KE family and no gross
abnormalities have been found (Watkins et al., 1999; Lai et al.,
2003). Instead only subtle effects are observed including changes
to graymatter density in regions of the cortex, thalamus and stria-
tum and functional activation differences during language tasks
in a language related area of the cortex (Broca’s area) and the stria-
tum (Watkins et al., 1999, 2002b; Liegeois et al., 2003). Hence, the
activity of FOXP2 in a subset of neurons throughout the brain
is thought to be essential for the proper development of neural
networks important for normal speech and language.
FOXP2 encodes a Forkhead-box (FOX) transcription factor
(Vernes et al., 2006). Related FOX transcription factors, such as
FOXP1, have also been implicated in cognitive disorders. FOXP1
and FOXP2 have high sequence homology, display overlapping
expression patterns and can form functional heterodimers to bind
target DNA. However, mutations in FOXP1 result in a broad
spectrum of cognitive impairments in patients including severe
intellectual disability, gross motor delay and autism spectrum dis-
order (Hamdan et al., 2010; Horn et al., 2010; Horn, 2011; O’roak
et al., 2011; Palumbo et al., 2013). Linguistic processing defects
have not been found in FOXP1 patients and, although speech
delay is sometimes seen, this is thought to be more related to
general cognitive impairments andmotor problems, rather than a
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speech/language specific effect (Bacon and Rappold, 2012). This
highlights the importance of directly studying FOXP2 function at
a molecular level, since it seems to be playing a unique and critical
role in language related circuitry that is different to even its most
closely related family member, FOXP1.
FOXP2 is expressed in a number of brain structures includ-
ing the cortex, basal ganglia, thalamus, cerebellum, midbrain, and
medulla (Ferland et al., 2003; Lai et al., 2003). Previous stud-
ies have identified a range of genomic regions bound by FOXP2
in human brain tissue, human neuron-like cells and embry-
onic mouse brain (Spiteri et al., 2007; Vernes et al., 2007, 2008,
2011). The putative FOXP2 targets identified in these studies
were known to act in pathways ranging from GABA signaling,
Wnt pathway signaling, neurogenesis, neuronal differentiation
and cell migration (Spiteri et al., 2007; Vernes et al., 2007,
2011). Consistent with the high number of FOXP2 target genes
involved in neurite outgrowth, Foxp2 (lowercase denotes the
mouse homolog) was found to promote the growth and branch-
ing of neurites inmedium spiny neurons (MSN) of the developing
mouse striatum (Vernes et al., 2011) and affect spine density in
mouse cortical neurons (Sia et al., 2013). Moreover, Foxp2 gene
disruption leads to abnormal neuronal activity and altered striatal
plasticity in mice (Groszer et al., 2008; French et al., 2012), impli-
cating this protein in controlling not only the morphology but
also the connectivity of neurons. Recently, an early developmen-
tal role for Foxp2 has been proposed in which Foxp2 enhances
the transition from radial glial precursor to cortical neuron in the
mouse brain (Tsui et al., 2013).
Given the developmental importance of FOXP2, and its puta-
tive roles in pathways such as neurogenesis, neuronal migration
and neurite outgrowth, we investigated if and how FOXP2 con-
tributes to human neuronal differentiation. For this purpose,
we chose a well-defined model of human neuronal differenti-
ation, the SHSY5Y human neuron-like cell line. SHSY5Y cells
can switch from a proliferative to a more differentiated neu-
ronal phenotype by stimulation with differentiation inducing
compounds, such as all-trans retinoic acid (RA) and/or growth
factors such as brain derived neurotrophic factor (BDNF) (Voigt
and Zintl, 2003; Agholme et al., 2010; Lopes et al., 2010; Dwane
et al., 2013). In this model, these factors reduce cell migra-
tion, increase expression of pro-neural gene markers, reduce
expression of pluripotency markers and promote the growth and
extension of long and extensively branched neurites, indicative
of neuronal differentiation (Voigt and Zintl, 2003; Lopes et al.,
2010).
This study demonstrates that FOXP2 induces molecular and
phenotypic features of neuronal differentiation. We show that
FOXP2 mediates changes in gene expression resembling those
occurring during differentiation to drive a more neuronal pheno-
type. FOXP2 controls similar gene expression programs to those
that are regulated by RA, and increases the expression of a retinoic
acid receptor central to RA signaling (RARβ). Interestingly, our
results suggest that FOXP2 increases the sensitivity of cells to RA,
influencing their molecular properties to drive neuronal differen-
tiation. The interaction of FOXP2 with retinoic acid pathways,
which are key to normal brain development and patterning,
may represent an important mechanism in controlling cell type
specific differentiation patterns and connectivity in language
related circuitry in the developing brain.
MATERIALS AND METHODS
CELL CULTURE AND REAGENTS
Stable SHSY5Y cells expressing human FOXP2 or the empty vec-
tor (EMPTY) generated previously (Vernes et al., 2007) were
grown at 37◦C in the presence of 5% CO2 in growth media;
DMEM:F12 media (Invitrogen, Carlsbad, CA, USA) supple-
mented with 10% Fetal Calf Serum (FCS; Sigma, St Louis, MO,
USA), 2mM L-glutamine (Sigma, St Louis, MO, USA), 1%
Non-essential amino acids (NEAA; Invitrogen, Carlsbad, CA,
USA) and 2mM Penicillin/Streptomycin (Sigma, St Louis, MO,
USA). Neuronal differentiation protocol involved treating cells
with 10μM all-trans retinoic acid (RA) in low serum media
(DMEM:F12, 2% Fetal Calf Serum, 2mM L-glutamine, 2mM
Penicillin/Streptomycin, 1% NEAA) for 5 days, followed by a
further 10 days of treatment with 50 ng/mL BDNF in serum
free media. All other retinoic acid treatments were performed in
low serum media. Transfections were carried out with Transfast®
(Promega, Madison, WI, USA), according to the manufacturers’
instructions.
QUANTITATIVE RT-PCR
Total RNA was extracted from cells harvested in TRIzol® reagent
using the RNeasy kit (QIAGEN, Venlo, NL) according to manu-
facturers instructions. RNA was extracted from three biological
replicates of SHSY5Y cells stably transfected either with human
FOXP2 or the empty control vector following culture in growth
media (Day 0) or following the differentiation protocol (Day
5, 10 or 15). Reverse transcription was performed as described
previously (Vernes et al., 2007).
PCR reactions utilized SYBR Green supermix (BioRad,
Hercules, CA, USA) as described previously (Vernes et al., 2007).
Primers specific for candidate genes and the control housekeeping
genes CYPA and POLR2F are described in Supplementary Table
S1. Quantitative PCR reactions were performed on the CFX96
Real-Time PCR Detection System (BioRad, Hercules, CA, USA)
according to manufacturers’ instructions.
Melting curve analysis was performed to assess the specificity
of the amplification. Data analysis was performed using CFX
manager software (BioRad, Hercules, CA, USA), and quantifica-
tion was performed via the comparative CT method (Livak and
Schmittgen, 2001). Fold changes are reported following normal-
ization to the geometric mean of two internal controls; CYPA and
POLR2F (Hoerndli et al., 2004; Agholme et al., 2010). Data are
expressed as mean ± standard deviation. Statistical significance
was assessed using students t-tests (two-tailed) for pairs of means
or ANOVA test for groups of three or more means followed by
post-hoc Bonferroni, Tukey or Dunnett calculation as specified.
RETINOIC ACID DOSE RESPONSE
SHSY5Y control (EMPTY) and FOXP2 cells were grown in low
serum media (as detailed above) and were treated with increas-
ing doses of RA (from 0.001 to 10μM) or no added RA for 3
days. Total RNA was extracted from three biological replicates per
treatment and reverse transcribed as described above. RT-PCR
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reactions were performed as described above. All fold changes
are reported relative to expression levels in the SHSY5Y control
(EMPTY) cell line in low serum media, following internal nor-
malization to POLR2F. Statistical significance was assessed using
ANOVA test followed by post-hoc Bonferroni calculation.
NEURITE OUTGROWTH ANALYSIS
Cells were plated onto poly-L-lysine coated coverslips at 3.3 × 104
cells per well. Cells were fixed using 4% Paraformaldehyde solu-
tion for 15min at room temperature and permeabilised in wash
solution (0.1% Triton X-100 in TBS). Antibodies were diluted in
Blocking Solution (1% Fish Gelatine, 0.1% Triton X-100, 5% BSA
in PBS). Cells were co-stained at 4◦C overnight, using an anti-
MAP2 rabbit polyclonal antibody (Chemicon, Temecula, CA,
USA). Cells were incubated with anti-rabbit FITC (Alexa Fluor
488,Molecular Probes, Carlsbad, CA, USA) for 1 h, shaking under
limited light exposure. Nuclei were visualized using mounting
media containing a DAPI counterstain (VectaShield). Cells were
viewed on a Zeiss Axiovert A-1 fluorescence inverted micro-
scope. Images were captured using a Zeiss AxioCam MRm cam-
era and Zen Software (Zeiss, Oberkochen, GER), and analyzed
using the neurite outgrowth function of Metamorph Version 7.8
(Molecular Devices, Sunnyvale, CA). Statistical significance was
assessed using students t-tests (two-tailed). Data are expressed as
the mean ± standard error of the mean (s.e.m.).
CELL MIGRATION ANALYSIS
Gap closure assays were performed according to manufacturer’s
recommendations (Ibidi, Martinsried, GER). 2 × 104 control
(EMPTY) or FOXP2 expressing cells (FOXP2) were seeded per
insert well (Ibidi Culture Inserts #80209) and cultured overnight
at 37◦C in the presence of 5% CO2. Culture media was supple-
mented with 1μMAphidicolin to inhibit cell division that would
obscure the effects of FOXP2 expression on migration. Cells were
allowed to migrate after removal of the inserts, and gap closure
was imaged for 72 h by time lapse microscopy (with one photo
taken every 10min).
Gap closure speed was determined by automated measure-
ments of the gap-size throughout the series of images, using
an ImageJ image analysis routine (developed by K. Jalink, NKI,
Amsterdam, The Netherlands). In short, images were normalized
with respect to intensity/contrast and subjected to the variance
filter in order to distinguish moving cells from the remaining gap.
The area of the remaing gap was quantified in each successive
image and plotted against time. Quantification was performed by
taking the migration values after 25, 50, and 75% gap closure for
non-FOXP2 expressing cells and comparing the migration val-
ues for FOXP2 positive cells at the same time points. Data are
expressed as mean of 6 image sets± standard deviation. Statistical
significance was assessed using Student’s t-tests (two-tailed).
GENE ONTOLOGY ANALYSIS
Gene Ontology (GO) analysis was performed using the
Webgestalt program (http://bioinfo.vanderbilt.edu/webgestalt/).
Over representation of gene ontology categories was determined
via hypergeometric testing using Benjamini and Hochberg multi-
ple testing correction (Zhang et al., 2005).
RESULTS
FOXP2 INDUCES EXPRESSION OF NEURONAL DIFFERENTIATION
MARKERS
Given that FOXP2 has previously been implicated in neurogene-
sis and neuronal development, we wanted to determine if FOXP2
affects the differentiation of neuron-like cells. SHSY5Y human
neuron-like cells were derived from a neuroblastoma biopsy and
are widely used for studying neuronal differentiation (Biedler
et al., 1973; Messi et al., 2008; Lopes et al., 2010; Xie et al., 2010;
Dwane et al., 2013). We established a neuronal differentiation
protocol in which cells are treated for 5 days with RA in low
serum (2% FCS) media, followed by a further 10 days of treat-
ment with BDNF in the absence of RA or serum. This protocol
led to dramatic morphological differentiation (Figures 1A,B) and
strong and reproducible increases in expression levels of neu-
ronal differentiation markers including microtubule associated
protein (MAP2), doublecortin (DCX) growth associated protein
43 (GAP43) and the neuronal microRNA mir-9 (Figure 1C).
We next set out to test whether FOXP2 could drive similar
gene expression changes when the cells were maintained in nor-
mal growth media (i.e., without the addition of RA or BDNF
supplements). Given that SHSY5Y cells do not express FOXP2
endogenously, we used SHSY5Y cells that were made to sta-
bly express human FOXP2 (FOXP2) or an empty vector control
(EMPTY) (Vernes et al., 2007) to determine the effect of FOXP2
in this system. We found that expression of FOXP2 protein alone
was sufficient to induce significant increases in neuronal mark-
ers of differentiation, including MAP2, DCX, and the pro-neural
microRNA mir-9-2 (Figure 1D).
FOXP2 MEDIATED GENE EXPRESSION CHANGES ARE CONSISTENT
WITH THOSE OCCURRING DURING NEURONAL DIFFERENTIATION
In addition to well-known differentiation markers such as MAP2
and DCX, neuronal differentiation involves widespread changes
in gene expression programs. We surveyed the literature for
additional differentiation related genes. We assembled a list
of 45 genes (Supplementary Table S1) including retinoic acid
receptors (RARs, RXRs, and RORs), genes known to respond
to retinoic acid or BDNF stimulation (e.g., as ASCL1, ID1-
3, BCL-2), genes involved in neurite outgrowth and migration
(e.g., NAV2, NEDD9) as well as putative FOXP2 target genes
including a retinoic acid receptor (RARβ), transcription factors
(BATF3, HOXD10, and ETV1), and neuronal differentiation fac-
tors (NEUROD2, NEUROD6 and FGF1) (Spiteri et al., 2007;
Vernes et al., 2007, 2011).
We first assessed the expression of these genes during neu-
ronal differentiation of control cells. Expression levels for
these genes were determined in the SHSY5Y control cell line
(EMPTY) during the differentiation protocol at the same four
time points as before; Day 0, Day 5, Day 10, and Day 15.
Significant changes were observed for the majority of genes
tested (Figure 2). The most strongly affected genes included
retinoic acid receptor β (RARβ; ∼50-fold upregulation), cellu-
lar retinoic acid binding protein 2 (CRABPII; ∼25-fold upreg-
ulation), regulator of G-protein signaling 2 (RGS2; ∼23-fold
upregulation), fibroblast growth factor 1 (FGF1; ∼30-fold upreg-
ulation), achaete-scute complex homolog 1 (ASCL1; ∼80%
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FIGURE 1 | Markers of neuronal differentiation show increased
expression in the presence of FOXP2. SHSY5Y control cells (EMPTY)
were differentiated using the RA/BDNF protocol outlined in Materials and
Methods for 15 days. (A) Cell morphology at Day 0, i.e., undifferentiated
SHSY5Y cells in normal growth media. (B) After 15 days exposure to
sequential RA and BDNF treatment to induce neuronal-like differentiation,
dramatic morphological changes can be seen including smaller cell bodies
and substantial increases in neurite outgrowth and complexity. Scale bar =
100μm. (C) Gene expression changes in SHSHY5Y control (EMPTY) cells
were assessed before (Day 0; D0) and during differentiation (Day 5, Day 10,
and Day 15). The differentiation markers MAP2, DCX, GAP43, and mir-9-2
were significantly upregulated after 5–10 days treatment. Significant
differences between groups was calculated using an ANOVA test followed
by post-hoc Dunnett calculation. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. (D)
Gene expression changes were assessed in SHSY5Y cells stably
transfected with either an empty vector (EMPTY) or human FOXP2 (FOXP2)
without differentiation (i.e., Day 0). FOXP2 expression resulted in
upregulation of the differentiation markers MAP2, DCX and mir-9-2 (primary
transcript) compared to empty vector transfected cells (EMPTY) when cells
were maintained in normal growth media (without added RA or BDNF).
Statistical significance was assessed using student’s t-tests (two-tailed).
∗p < 0.05, ∗∗p < 0.01. All data are the average of three biological replicates
expressed as mean ± standard deviation.
downregulation) and Delta-like ligand 3 (DLL3; ∼80% down-
regulation). See Supplementary Table S2 for gene expression
summary.
In order to determine if FOXP2 was able to regulate this set
of differentiation related genes, we then compared their expres-
sion levels between untreated SHSY5Y control cells (EMPTY) and
FOXP2 expressing cells (FOXP2) when cells were maintained in
normal growth media (equivalent to Day 0). More than half of
the genes assayed displayed altered expression levels in response
to FOXP2 expression (Figure 3), suggesting that FOXP2 is reg-
ulating a wide range of differentiation related genes even in
normal growth media (i.e., without the addition of RA/BDNF
supplements). Moreover these expression changes were similar
to those induced by the RA/BDNF differentiation protocol in
control (EMPTY) cells. Targets previously identified via FOXP2-
ChIP, including CNTNAP2, SLIT1, BATF3, and DLL3, were sig-
nificantly downregulated in response to FOXP2 expression. The
pro-neural transcription factor ASCL1was strongly repressed and
TNR, AQP1, and the retinoic receptors RXRa and RORg were
mildly downregulated (Figure 3 and Supplementary Table S2).
The majority of these genes were also downregulated during at
least one time point of differentiation in control (EMPTY) cells
(Figure 2; Supplementary Table S2).
FOXP2 has been widely described as a transcriptional repres-
sor, however a number of genes, including some previously
identified as direct FOXP2 targets, were upregulated upon FOXP2
expression (Figure 3). Retinoic acid receptors such as RORβ and
two isoforms of the putative FOXP2 target gene RARβ (isoforms
RARβ-001, RARβ-002) were upregulated 2–5-fold. Of note, RARβ
has multiple promoters producing at least four different pro-
tein coding transcripts, but FOXP2 was previously only shown to
bind to the shared RARβ-001/002 promoter (Vernes et al., 2007).
Interestingly one of the earliest genes expressed during retinoic
acid induced differentiation, NEDD9, was very highly upregu-
lated by FOXP2 (∼5 fold increase). FOXP2 target genes previously
identified via ChIP-Seq including RGS2, SPOCK1, SYK, TJP2,
FGF1, and ETV1 were upregulated, as were novel targets NAV2,
HES1, and BCL-2 (Figure 3). This demonstrates that FOXP2
has the capacity to cause target gene expression to increase as
well as to decrease, and thus should not be referred to only as
a transcriptional repressor. A summary of all FOXP2 mediated
gene expression changes as well as all changes that occur dur-
ing differentiation in control cells can be found in Supplementary
Table S2.
Overall, the presence of FOXP2 is sufficient to drive gene
expression changes that resemble those occurring during SHSY5Y
neuronal differentiation induced by RA and BDNF. This includes
upregulation of RARβ, a nuclear receptor central to RA signal-
ing that directly regulates the expression of downstream gene
networks. FOXP2 also affected the expression of a range of
genes known to be involved in RA signaling including pro-
neural transcription factors (such as ASCL1) and proteins that
directly affect differentiation phenotypes (NAV2 and NEDD9).
These data demonstrate that the FOXP2 transcription factor acti-
vates a complex gene expression program that drives neuronal
differentiation.
FOXP2 POSITIVE CELLS ARE MORE RESPONSIVE TO RETINOIC ACID
The effects of RA in the developing brain are highly dependent
on concentration gradients and the level of RA that cells are
exposed to can influence their differentiation response (Maden,
2002; White et al., 2007; Rhinn and Dolle, 2012). Moreover, dur-
ing development cells display a “sensitive period” in which the
effects of RA are most severe (Sive et al., 1990; Holson et al., 2001;
Yamamoto et al., 2003; Luo et al., 2004). This suggests that the
amount of available RA, as well as the internal molecular state
of the cell, is important to regulate the response induced by RA.
Thus, we investigated if the presence of FOXP2 affected the way
cells responded to RA treatment.
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FIGURE 2 | Widespread gene expression changes are induced during
neuron-like differentiation of human SHSY5Y cells. SHSY5Y (EMPTY)
control cells (which do not express any FOXP2 protein) were induced to
differentiate via sequential treatment with RA and BDNF. Gene expression
changes were assessed before (Day 0) and during differentiation (Day 5, Day
10, and Day 15). To observe the effect of differentiation, all gene expression
levels were normalized to their own expression at Day 0. (A,B) Massive
inductions were observed for a subset of genes including RARβ (∼50 fold),
CRABPII, FGF1, and RGS2 (∼25 fold). (C) Many other genes were more
mildly (2–7 fold), but significantly induced. (D) A few genes were strongly
downregulated during differentiation including ASCL1, CNTNAP2, and DLL3
(80–90% reduction in expression). NEUROD2, NEUROD6, and DLL1 could
not be assessed as transcripts could not be detected in any samples,
suggesting that these genes are not expressed in SHSY5Y cells. Data are the
average of three biological replicates expressed as mean ± standard
deviation. Significant differences between groups was calculated using an
ANOVA test followed by post-hoc Dunnett calculation. ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.001.
Control (EMPTY) and FOXP2 expressing cells were treated
with varying RA doses; low serum media alone (media) or
low serum media containing a range of RA doses from low
(0.001μM) to high (10μM) concentration. The lowest dosage
had previously been shown to be sufficient to induce expression
changes in SHSY5Y cells (Urban et al., 2010). Indeed, all doses of
RA were able to significantly upregulate RARβ andNEDD9 and to
downregulate DLL3 in the control (EMPTY) cell lines (Figure 4).
Significant downregulation of ASCL1 in control cells could only
be observed after high dose (10μM) RA treatment in control
cells (Figure 4C). In the FOXP2 expressing cells, the molecular
changes occurring in response to RA treatment were significantly
stronger than in controls. Both RARβ and NEDD9 were more
strongly induced by a range of RA doses in FOXP2 expressing
cells compared to control cells and this effect was particularly
striking for NEDD9 at the highest dose (10μM RA). FOXP2
strongly downregulated ASCL1 in an RA independent fashion
until cells were exposed to high dose RA (10μM), at which point
significantly stronger repression of ASCL1 was observed by the
combination of FOXP2 plus RA than either treatment alone.
The combination of FOXP2 expression and RA treatment also
enhanced the repression of DLL3 at most RA doses.
Given that the effect of expressing FOXP2 in the presence of
RA produced greater magnitude effects on gene expression lev-
els than either treatment alone, we suggest that the presence of
FOXP2 is making these cells more sensitive to retinoic acid lev-
els, i.e., FOXP2 may alter the internal state of cells to allow a
larger induction of signaling via downstream networks in a dose
dependent manner.
FOXP2 PROMOTES INCREASED NEURITE OUTGROWTH IN RESPONSE
TO RETINOIC ACID
We have previously shown that endogenous expression of murine
Foxp2 in neurons promotes the growth and branching of neurites
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FIGURE 3 | FOXP2 regulates the expression of genes related to human
neuronal differentiation. The same genes tested in Figure 2 were assessed
for regulation by FOXP2 in undifferentiated cells. Gene expression levels were
compared between SHSY5Y control cells that do not express FOXP2 (EMPTY)
or FOXP2 expressing counterparts (FOXP2), in normal growth media (i.e.,
equivalent to Day 0). (A) FOXP2 strongly upregulates multiple isoforms of the
RARβ receptor and the orphan nuclear receptor (RORb). Mild but significant
reductions in RORg and RXRa expression were also observed in FOXP2
expressing cells. (B,C) A number of other genes induced by differentiation
were also upregulated by FOXP2 in the absence of differentiation stimulus,
including RGS2, NEDD9, SYK, BCL-2, and NAV2. (D) In normal growth media,
FOXP2 strongly downregulated ASCL1, CNTNAP2, and DLL3, all of which are
significantly repressed during neuronal differentiation. Underlined genes have
shown evidence that FOXP2 binds directly to their promoter regions in ChIP
assays (Spiteri et al., 2007; Vernes et al., 2007, 2011). Data are the average of
three biological replicates expressed as mean ± standard deviation. Statistical
significance was assessed using student’s t-tests (two-tailed). ∗p < 0.05,
∗∗p < 0.01, ∗∗∗p < 0.001.
in the mouse (Vernes et al., 2011). SHSY5Y FOXP2 cells also dis-
playedmore neurite growth than their control (EMPTY) counter-
parts when growing in normal growth media (Figure 5A, upper
panels). Furthermore, retinoic acid differentiation of SHSY5Y
cells induces the growth of long, extensively branched neurites
(Figures 1A,B)(Voigt and Zintl, 2003; Lopes et al., 2010). Given
the increased molecular response to retinoic acid exposure in
FOXP2 positive cells, we investigated whether expression of
FOXP2 affected the induction of neurite outgrowth by retinoic
acid.
In order to assess the effect of FOXP2 on neurite outgrowth
and branching, we exposed cells to retinoic acid to initiate neurite
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FIGURE 4 | FOXP2 expression makes cells more responsive to retinoic
acid. FOXP2 expression influences the cellular response to RA. Gene
expression changes were measured in control (EMPTY) or FOXP2 expressing
cells following treatment with varying levels of RA doses; ranging from 0.001
to 10μM RA. Low serum media (“media”) containing 2% FCS acted as the
baseline condition. In both EMPTY and FOXP2 cells, exposure to RA induces
the expression of RARβ and NEDD9 (A,B), and represses ASCL1 and DLL3
(C,D). The effect on gene expression levels of adding RA is greater in cells
that are expressing FOXP2 positive cells, i.e., larger increases or decreases in
expression are observed in the FOXP2 positive cells compared to the control
cells. This effect is particularly striking for ASCL1 and NEDD9 at the highest
RA concentration. Data are the average of three biological replicates
expressed as mean ± standard deviation. Significant difference between all
groups was calculated using an ANOVA test followed by post-hoc Bonferroni
calculation and significance is given for the differences between the EMPTY
and FOXP2 groups where ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
formation in SHSY5Y FOXP2 and control (EMPTY) cells. RA
treated cells that expressed FOXP2 showed more neurite growth
than the control cell line (EMPTY) (Figure 5A, lower panels).
FOXP2 expression significantly increased the number and length
of protrusions that grew in response to RA treatment (Figure 5B,
left panel). The majority of control (EMPTY) cells (83%) had
either no outgrowths or “short” outgrowths (<30μm) follow-
ing RA exposure (Figure 5C, upper panel). In contrast, only 62%
of FOXP2 expressing cells were in the no outgrowth or “short”
outgrowth category. FOXP2 expressing cells were more likely
to have “long” outgrowths (i.e., protrusions exceeding 60μm)
(Figure 5C, lower panel).
FOXP2 expression significantly increased the number of
branches observed per cell (Figure 5B, right panel). Processes
in the majority of control (EMPTY) SHSY5Y cells were not
branched and no EMPTY cells had more than four branches
(Figure 5D, upper panel). FOXP2 expression increased branch-
ing, with a higher proportion of cells displaying branched out-
growths, a small number displaying as many as 14 branches
(Figure 5D, lower panel). This illustrates that FOXP2 drives
growth and branching of neurites during retinoic acid induced
differentiation, and suggests that at both a molecular and a mor-
phological level, FOXP2 expressing cells show increased respon-
siveness to retinoic acid.
FOXP2 EXPRESSION IMPAIRS NEURONAL CELL MIGRATION
RA induced differentiation reduces migration/invasion of
SHSY5Y cells (Voigt and Zintl, 2003; Messi et al., 2008) and
controlling the migration of cells in the brain is essential to
establishing neuronal circuitry during development (Marin
et al., 2010). Here, we assessed the effect of FOXP2 expression
on SHSY5Y migration in gap closure assays. Using time lapse
microscopy, we measured gap closure speed by EMPTY and
FOXP2 cells. We found that FOXP2 expression reduced cell
migration (Figure 6A). The effect of FOXP2 on migration was
highly significant when assessing time to gap closure (Figure 6B).
When control cells had reached 25, 50, and 75% gap closure,
FOXP2 positive cells had reached only 14, 30, and 50% closure—a
significantly reduced migration rate. Thus, in addition to pro-
moting molecular and morphological features of differentiation,
FOXP2 expression results in reduced speed of migration, a key
feature of retinoic acid induced neuronal differentiation.
DISCUSSION
FOXP2 has garnered significant attention due to its importance
for normal speech and language development in humans. FOXP2
acts as a transcription factor and a diverse list of putative targets
have been identified in a range of model systems, suggesting a
role for FOXP2 in cellular processes such as neurite outgrowth
(Vernes et al., 2011) and synapse development (Schulz et al., 2010;
Sia et al., 2013). Indeed, mouse and songbird models of FOXP2
have revealed important roles in synaptic plasticity and neuronal
connectivity (Haesler et al., 2007; Groszer et al., 2008; French
et al., 2012; Murugan et al., 2013). However, it is still unclear
how transcriptional programs controlled by FOXP2 affect neu-
ronal development. In this study we demonstrate the importance
of FOXP2 for human neuronal differentiation using a neuron-like
model system.
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FIGURE 5 | FOXP2 promotes increased neurite outgrowth in response to
retinoic acid. (A)Example brightfield pictures demonstrating increased neurite
growth in FOXP2 positive cells compared to EMPTY control cells both in normal
growth media (upper panels) or after RA treatment for 3 days (lower panels) (B)
SHSY5Y control (EMPTY) or FOXP2 cells were exposed to 10μMRA for 3 days
before measurement of neurite length and complexity. FOXP2 expression
resulted in highly significant increases in total outgrowths (p = 1.92E-08),
mean process length (p = 7.36E-03) and max process length (p = 1.01E-06) as
well as the number of cell processes (p = 3.11E-09) and branches
(p = 1.76E-06). Data are the average of three biological replicates (N = 228
EMPTY cells and 223 FOXP2 cells) expressed as mean ± s.e.m. Statistical
significance was assessed using students t-tests (two-tailed). ∗∗p < 0.01,
∗∗∗p < 0.00001. (C) Total outgrowths in EMPTY vs. FOXP2 cells. The majority
(Continued)
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FIGURE 5 | Continued
(83%) of EMPTY (control) cells had either no measurable neurites, or “short”
outgrowths (i.e., <30μm total outgrowths). By comparison, this number was
only 62% for FOXP2 expressing cells. FOXP2 expressing cells were far more
likely to show long neurite growth, with 20% of cells having “long” neurites
(totalling more than 60μm), whereas only 5% of EMPTY cells had growth at
or above this length. (D) FOXP2 significantly increases the number of
secondary branches per cell. The majority of control cells (EMPTY) had no
secondary branchpoints (93%), whereas when FOXP2 was expressed, only
74% of cells had no branches. 7% of EMPTY cells had between 1–4 branches,
while 22.5% had 1–4 branches (compared to 9% in EMPTY cells) and 3.6%
of FOXP2 expressing cells and more than four branches respectively. EMPTY
cells never displayed more than four branches. Data are the average of three
biological replicates (N = 228 EMPTY cells and 223 FOXP2 cells).
FIGURE 6 | FOXP2 affects the rate at which SHSY5Y cells can
migrate. Invasion assays were used to assess the migration of SHSY5Y
cells expressing FOXP2 compared to control cells that are FOXP2
negative (EMPTY). Cells expressing FOXP2 migrate more slowly into the
empty space. (A) Gap closure for EMPTY and FOXP2 cells over 72 h
timecourse. Cells expressing FOXP2 did eventually close the gap, but did
so at a later timepoint, demonstrating a quantifiably slower migration
speed compared to control cells. (B) The average invasion frequency
was calculated once EMPTY cells had reached 25, 50, and 75% gap
closure. At each timepoint, FOXP2 expressing cells had completed
significantly less gap closure (14, 30, and 50% closure respectively).
Data is the average of 6 replicates expressed as mean ± standard
deviation. Statistical significance was assessed using students t-tests
(two-tailed). ∗p < 0.05, ∗∗p < 0.01.
We demonstrated that in normal growth media, FOXP2
increased the expression of neuronal markers such as MAP2,
DCX, and mir-9 and directed a transcriptional program that was
consistent with retinoic acid induced differentiation. In addition
to these molecular effects, we showed that FOXP2 induces phe-
notypic changes characteristic of neuronal differentiation such as
increased neurite outgrowth and reduced migration. Neuronal
migration and neurite outgrowth are tightly linked and many
of the genetic mechanisms underlying these processes are shared
(Marin et al., 2010). Throughout development, neurons migrate
along tightly regulated paths to reach their correct destination
before extending their processes to form connected neuronal
circuitry. Control of both neuronal cell migration and neurite
outgrowth are thus essential for normal brain development and
defects in outgrowth or migration can lead to neurodevelopmen-
tal disorders such as intellectual disability and have been linked
to disorders involving language impairment such as autism and
dyslexia (Mcmanus and Golden, 2005; Paracchini et al., 2007;
Wegiel et al., 2010; Bellon et al., 2011; Liu, 2011; Carrasco et al.,
2012; Carrion-Castillo et al., 2013).
In vivo studies have illustrated the importance of FOXP2 for
normal brain development. Individuals carrying heterozygous
mutations of FOXP2 display a complex speech and language dis-
order phenotype involving impaired articulation caused by an
inability to coordinate the complex sequences of orofacial mus-
cle movements required during speech (developmental orofacial
dyspraxia; OMIM 602081), accompanied by both expressive and
receptive linguistic and grammatical processing defects (Vargha-
Khadem et al., 1995, 1998; Watkins et al., 2002a). Corresponding
differences in brain activation in language related areas during
linguistic tasks has been observed in these affected individuals,
suggesting that disruption of FOXP2 is causing subtle network
connectivity and/or activation differences (Watkins et al., 1999,
2002b; Liégeois et al., 2003). However, it is still poorly under-
stood how the molecular functions of FOXP2 can produce such
a specific phenotype related to human speech and language cir-
cuitry. An intriguing finding of our study is that FOXP2 positive
cells are more sensitive to retinoic acid treatment. Cells that
both express FOXP2 and were RA treated displayed increased
responses compared to either treatment alone. Our findings sug-
gest that the transcriptional program enacted by FOXP2 alters
the molecular composition of neurons, allowing these cells to
respond differently to environmental retinoic acid cues driving
neuronal differentiation. Retinoic acid signaling regulates prolif-
eration, migration and differentiation of cells and is extremely
important for normal brain development, contributing to fore-
brain, hindbrain and spinal cord patterning (Gudas, 1994; Rhinn
and Dolle, 2012). RA induction of neuronal differentiation is
mediated by a combination of morphogen signaling gradients
acting on cells during a refractive “sensitive period” in which the
appropriate gene expression changes can be induced to produce
different neuronal fates (Sive et al., 1990; Holson et al., 2001;
Maden, 2002; Yamamoto et al., 2003; Luo et al., 2004; White et al.,
2007; Rhinn and Dolle, 2012). FOXP2 is only expressed in a sub-
set of neurons in select brain regions, such as deep layer cortical
neurons, Purkinje cells of the cerebellum and a subset of medium
spiny neurons (MSNs) of the striatum (Ferland et al., 2003; Lai
et al., 2003). The importance of having FOXP2 expression in
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these specific neuronal populations during development is not
understood. However, given the findings presented here, FOXP2
may sensitize developing neurons to RA and thus program these
subsets of neurons to respond differently to environmental RA
cues than surrounding cells. In future, it will be of great inter-
est to determine if this could specifically affect the differentiation
and/or incorporation of FOXP2 positive cells into functioning
neuronal circuitry, such as those subserving language.
The increased sensitivity to RA is likely mediated by FOXP2
inducing transcriptional changes across a range of molecules
that we identified as acting downstream of both retinoic acid
and FOXP2. This internal change of cellular components may
collectively result in a greater response to retinoic acid levels.
Mechanistically this may be occurring by affecting the classical
RA pathway, or by affecting the non-genomic RA pathway (or
potentially a combination of the two).
The classical RA pathway involves retinoic acid entering the
nucleus and binding to transcription factors such as the retinoic
acid receptors (RAR) (Gudas, 1994; Balmer and Blomhoff, 2002).
Cellular retinoic acid binding protein II (CRABPII) transports
intracellular retinoic acid into the nucleus so that it can inter-
act with RARs (Gudas, 1994). Thus, CRABPII is able to modulate
the cellular response to RA, the more CRABPII that is present,
the more environmental RA can be transported into the nucleus
(Delva et al., 1999; Dong et al., 1999). Once in the nucleus,
RA binds to receptors such as RARβ to induce conformational
changes that result in the differential regulation of downstream
target genes and induce neuronal differentiation and increased
neurite outgrowth (Gudas, 1994; Puttagunta et al., 2011; Al
Tanoury et al., 2013; Rochette-Egly, 2014). Both CRABPII and
RARβ have previously been shown to be strongly upregulated by
exposure to retinoic acid (Hewson et al., 2002) and we observed
the same effects in our system. Furthermore, we found that that
both of these critical modulators of the classical RA pathway were
upregulated by FOXP2 in normal growth media. Thus, we can see
how FOXP2 causes an increase in the pool of both CRABPII and
RARβ with which RA can interact. Conceivably this could lead to
greater magnitude responses either at a gene expression or pheno-
type level being evoked by RA treatment in FOXP2 positive cells
compared to FOXP2 negative (EMPTY) counterparts.
FOXP2 may also affect the non-genomic RA pathway which
involves the rapid activation of kinase signaling pathways, such
as MAPK or ERK as well as post-transcriptional control of gene
expression (Rochette-Egly, 2014). These effects can again be
mediated by RAR’s, however the pool of RARs associated with
the non-genomic pathway are not localized to the nucleus and
thus do not directly mediate transcriptional changes (Al Tanoury
et al., 2013; Rochette-Egly, 2014). Non-genomic effects of RA
have been observed in hippocampal neurons where synaptically
localized RARα interacts with mRNA to control translation levels
in an RA dependent fashion, leading to altered synaptic plastic-
ity (Aoto et al., 2008; Sarti et al., 2013). RARβ is not expressed
in the hippocampus and thus it is not yet clear if it is able to
perform similar synaptic functions to RARα in other tissues, how-
ever in primary striatal neurons of the developing mouse brain
we have observed localization of the RARβ protein at synapses
(data not shown), suggesting it has the potential to modulate
synaptic protein levels in a similar fashion to RARα. By increas-
ing the RARβ levels, FOXP2 may again be influencing the pool of
molecules that can respond to RA exposure and thus the level of
signaling through the non-genomic RA pathway.
Interestingly, RARβ has been shown to be essential for the
normal patterning of the postnatal striatum (Liao et al., 2008),
and both RARβ and FOXP2 are highly expressed in the stria-
tum, throughout development and into adulthood (Ferland et al.,
2003; Lai et al., 2003; Takahashi et al., 2003; Liao et al., 2005).
The striatum represents a site of pathology both structurally
and in measures of functional activation during language related
processing tasks in speech/language disorder patients carrying
FOXP2 mutations (Vargha-Khadem et al., 1998; Watkins et al.,
2002b). Given the upregulation of RARβ by FOXP2, it will be
of interest to determine if striatal patterning occurs in a FOXP2
dependent fashion and how patterning is affected by FOXP2
mutation. The importance of RA signaling for normal striatal
development and the interplay between FOXP2 and RA respon-
sive pathways, may indicate a neurogenetic mechanism by which
FOXP2 is able to produce subtle but specific phenotypic effects in
language related areas of the brain such as the striatum.
Retinoic acid signaling is also important for the specifica-
tion of neuronal identity in the developing brain. In the neural
tube, RA directs the differentiation of cells into serotonergic
hindbrain or V3 spinal cord neurons and ASCL1 (a proneu-
ral transcription factor also known as MASH1) has been shown
to be the crucial downstream molecule directing this cell fate
switch (Jacob et al., 2013). We found that ASCL1 was strongly
downregulated by either FOXP2 or by retinoic acid induced dif-
ferentiation. Furthermore, ASCL1 downregulation following RA
treatment was significantly enhanced in FOXP2 expressing cells
compared to controls. Another FOX family member, FOXO3, has
been shown to repress ASCL1 to drive the switch from neural pro-
genitor cell to differentiated neuron (Webb et al., 2013). In these
cells ASCL1 and FOXO3 have been shown to bind to enhancers
of a large number of overlapping genes in a competitive manner
(Webb et al., 2013). Given the strong downregulation of ASCL1
by FOXP2 that we observed, coupled with the high conservation
in the FOX family of both the FOX DNA binding domain and
the core DNA motif recognized by these transcription factors,
it is plausible that a similar model of action applies to FOXP2
positive neurons. Comparing our previously identified FOXP2
target genes (Spiteri et al., 2007; Vernes et al., 2007, 2011) with
the ASCL1 targets from Webb et al. (2013), we found a very high
degree of overlap (N = 387). These genes, putatively regulated by
both FOXP2/ASCL1, displayed a significant over-representation
of genes involved in neuronal differentiation (adjP = 2.78e-10)
such as WNT5A, EFNB2, SEMA3A/6A, and NRP2 (Vernes et al.,
2007, 2011). Hence the regulation of ASCL1 by FOXP2 may be a
key step in driving differentiation in FOXP2 positive neurons.
We have shown that both molecular and phenotypic fea-
tures of human neuronal differentiation can be promoted by
the FOXP2 protein. In addition to upregulating classical neu-
ronal markers, FOXP2 regulated the expression of a large num-
ber of differentiation responsive genes in a manner that was
consistent with a more differentiated neuronal state. This tran-
scriptional program is accompanied by phenotypic changes that
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occur during differentiation, i.e., increased neurite outgrowth
and reduced neuronal migration. Intriguingly, our study suggests
that FOXP2 causes cells to be more responsive to retinoic acid
exposure. The mechanism for this sensitivity is likely related to
FOXP2’s ability to control the expression of retinoic acid respon-
sive genes and may present a novel mechanism for controlling cell
type specific differentiation patterns in the developing brain. In
the future, it will be essential to determine in vivo if FOXP2 con-
trols the responsiveness of neurons to RA during development.
These findings demonstrate the importance of FOXP2 for human
neuronal differentiation and illustrate how mutations could lead
to aberrant differentiation of neurons in the developing brain.
This link between FOXP2 function and RA pathways may point
to a novel role for retinoic acid signaling in the development of
language related neuronal circuitry.
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